PDS Biotechnology
Rory Cullinane is an accomplished professional with extensive experience in quality and regulatory compliance within the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Quality at PDS Biotechnology since October 2022, Rory has previously held key leadership roles including Vice President of Quality & Regulatory Compliance at BioCentriq, Senior Director and Head of Quality at Mitsubishi Tanabe Pharma America and Advaxis, Inc., and various managerial positions at Sanofi Genzyme, Merck, and Schering-Plough. Rory's educational background includes a Master's degree in Industrial Engineering from University College Dublin and a Bachelor’s degree in Applied Sciences from Dublin Institute of Technology - Trinity College Dublin.
This person is not in any offices
PDS Biotechnology
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers;PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers.PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.